The civic record
Read. Follow. Verify.Indiana House Bill 1328 Caps Hospital Charges for Administered Drugs at 120% of Medicare Rates
Last action · January 12, 2026: Representative Goss-Reaves added as coauthorSponsors: Julie McGuire and 2 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Prohibits a hospital from billing for an administered drug an amount that exceeds the lesser of the following: (1) 120% of the Medicare reimbursement rate for the administered drug. (2) The amount the hospital bills for the administered drug on June 30, 2026. Creates an exception. Requires a hospital to update the Medicare reimbursement rate for an administered drug on January 1 and July 1 of each year.
Patients receiving drugs via injection, infusion, or ingestion at non-exempt hospitals face new caps on charges, while licensed hospitals must alter their billing systems and update pricing benchmarks twice annually.
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
hospitals
Licensed hospitals are restricted from billing above specified caps for administered drugs and must update rates biannually.
patients receiving administered drugs
Patients receiving drugs via injection, infusion, or ingestion are subject to new statutory billing ceilings.
Medicaid program
The Medicaid program is explicitly exempted from the requirements of the chapter.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Which hospitals are exempt from these billing limits?
How often must hospitals update their drug reimbursement rates under the bill?
What defines an administered drug?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in House committee.
Procedural history
4 actions- Jan 12, 2026HouseRepresentative Goss-Reaves added as coauthor
- Jan 6, 2026HouseIntroducedFirst reading: referred to Committee on Public Health
- Jan 6, 2026HouseCoauthored by Representative Barrett
- Jan 6, 2026HouseAuthored by Representative McGuire
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Introduction of Price Ceilings on Hospital Administered Drugs
The bill introduces a statutory cap linking hospital billing rates for administered drugs directly to Medicare Part B reimbursement levels.
Connected Entities
Sources
iga.in.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 75)
- Controversy65Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools